Amelioration of NK cell function driven by Vα24+ invariant NKT cell activation in multiple myeloma

Copyright © 2017 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 187(2018) vom: 01. Feb., Seite 76-84
1. Verfasser: Iyoda, Tomonori (VerfasserIn)
Weitere Verfasser: Yamasaki, Satoru, Hidaka, Michihiro, Kawano, Fumio, Abe, Yu, Suzuki, Kenshi, Kadowaki, Norimitsu, Shimizu, Kanako, Fujii, Shin-Ichiro
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Innate immunity Multiple myeloma NK cells NKT cells Antigens, CD1d Antigens, Differentiation, T-Lymphocyte Antineoplastic Agents CD1D protein, human mehr... T Lineage-Specific Activation Antigen 1 Galactosylceramides Glucocorticoids KLRK1 protein, human NK Cell Lectin-Like Receptor Subfamily K Receptors, Antigen, T-Cell Valpha24 protein, human alpha-galactosylceramide